|
|
| | 2-Propenamide, N-[4-[1-(3-aminobenzoyl)-4-piperidinyl]butyl]-3-(3-pyridinyl)-, (2E)- Basic information |
| | 2-Propenamide, N-[4-[1-(3-aminobenzoyl)-4-piperidinyl]butyl]-3-(3-pyridinyl)-, (2E)- Chemical Properties |
| Boiling point | 691.0±55.0 °C(predicted) | | density | 1.166±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | | form | Solid | | pka | 14.12±0.46(predicted) |
| | 2-Propenamide, N-[4-[1-(3-aminobenzoyl)-4-piperidinyl]butyl]-3-(3-pyridinyl)-, (2E)- Usage And Synthesis |
| Uses | Nampt-IN-15 (Example 3) is an Nampt inhibitor. Nampt-IN-15 shows cytotoxicity against BxPC-3, HepG2, L540cy and MOLM-13, with IC50s of 38.5 nM, 8 nM, 8.5 nM, 7 nM respectively[1]. | | References | [1] Christopher Scott NEUMANN, et al. Targeted delivery of nicotinamide adenine dinucleotide salvage pathway inhibitors. Patent. WO2018075600 |
| | 2-Propenamide, N-[4-[1-(3-aminobenzoyl)-4-piperidinyl]butyl]-3-(3-pyridinyl)-, (2E)- Preparation Products And Raw materials |
|